Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease.

about

Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease.

Item

http://www.wikidata.org/entity/Q38732142

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Serum-inducible protein (IP)-1 ...... alcoholic fatty liver disease.

@en

type

Item

label

Serum-inducible protein (IP)-1 ...... alcoholic fatty liver disease.

@en

prefLabel

Serum-inducible protein (IP)-1 ...... alcoholic fatty liver disease.

@en

P1476

Serum-inducible protein (IP)-1 ...... alcoholic fatty liver disease.

@en

P2093

Akinobu Takaki

http://www.w3.org/2001/XMLSchema#string

Atsuko Nakatsuka

http://www.w3.org/2001/XMLSchema#string

Fusao Ikeda

http://www.w3.org/2001/XMLSchema#string

Hidenori Shiraha

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Okada

http://www.w3.org/2001/XMLSchema#string

Jun Wada

http://www.w3.org/2001/XMLSchema#string

Kazuhide Yamamoto

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Nouso

http://www.w3.org/2001/XMLSchema#string

Kazuko Koike

http://www.w3.org/2001/XMLSchema#string

Koji Miyahara

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH)

Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.

Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network

Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.

Insulin Signaling in Insulin Resistance States and Cancer: A Modeling Analysis.

Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice

P2888

s12072-016-9773-y

P304

115-124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12072-016-9773-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1047474845

http://www.w3.org/2001/XMLSchema#string

P698

27826704

http://www.w3.org/2001/XMLSchema#string